Donaldson Company Reports Q4 with $0.94 EPS, $935M in Revenue
Donaldson Company, Inc. (NYSE: DCI), a global leader in technology-led filtration products and solutions, reported a robust performance for the fourth quarter of fiscal 2024. Sales reached $935 million, marking a 6.4% increase from $879.5 million in the same period last year. This growth was primarily driven by increased volume and favorable pricing benefits.
The company achieved a GAAP earnings per share (EPS) of $0.90, up 20% from $0.75 in the fourth quarter of fiscal 2023. Adjusted EPS stood at $0.94, reflecting the company’s strong operational efficiency. The Mobile Solutions segment saw a 6.1% increase in sales, driven by a 12.6% growth in Aftermarket sales.
However, the segment faced challenges in Off-Road and On-Road sales, which declined by 13.0% and 11.8%, respectively. The Industrial Solutions segment also performed well, with a 3.9% increase in sales, bolstered by a 39.7% rise in Aerospace and Defense sales.
The Life Sciences segment experienced a significant 20.7% increase in sales, attributed to volume growth in Disk Drive and Food and Beverage sectors. Gross margin for the quarter was 35.8%, up from 34.1% in the previous year, driven by select input cost deflation and leverage on higher sales.
Operating expenses as a percentage of sales improved to 20.2% from 20.4% last year, showcasing the company’s operational efficiency. Overall, Donaldson’s operating margin increased to 15.6% from 13.7% in the same period last year, reflecting the company’s strong financial health.
Donaldson Company, Inc. Beats Q4 EPS Expectations, Slightly Short on Revenue
Donaldson’s fourth-quarter performance exceeded market expectations. The company reported a GAAP EPS of $0.90, surpassing the expected EPS of $0.89. The adjusted EPS of $0.94 further highlighted the company’s strong financial management and operational efficiency.
However, the reported sales of $935 million fell slightly short of the expected $942.85 million, indicating some challenges in achieving the anticipated revenue growth. Despite the slight shortfall in sales, Donaldson’s robust margin expansion and operational efficiency contributed to a strong overall performance.
The company’s ability to manage costs effectively and leverage higher sales volumes played a crucial role in exceeding EPS expectations. The Mobile Solutions segment’s Aftermarket sales growth and the Industrial Solutions segment’s strong Aerospace and Defense performance were key drivers of this success.
The company’s strategic initiatives, including footprint optimization and cost reduction programs, also contributed to its strong performance. These initiatives are expected to enhance the company’s long-term profitability and operational efficiency, positioning Donaldson for continued growth and success in the coming years.
Donaldson Expects Adj. EPS Between $3.56 and $3.72 for Full Year 2025
Looking ahead to fiscal 2025, Donaldson is optimistic about its growth prospects. The company expects full-year sales to increase by 2% to 6%, with adjusted EPS projected to be between $3.56 and $3.72.
This guidance reflects the company’s confidence in its strategic initiatives and its ability to navigate market challenges effectively. Donaldson’s focus on operational efficiency and cost management is expected to drive sustained profitability and growth.In the Mobile Solutions segment, sales are forecasted to be flat to up 4% year over year.
Off-Road sales are projected to increase in the low-single digits, driven by market share gains, while On-Road sales are expected to decline in the low-double digits due to an exit from non-strategic products and weak end-market conditions.
Aftermarket sales are forecasted to grow in the low-single digits, supported by strong vehicle utilization rates and market share gains.The Industrial Solutions segment is expected to grow by 4% to 8%, with high-single-digit growth anticipated in Industrial Filtration Solutions (IFS).
Aerospace and Defense sales are projected to remain flat after cycling through strong comparisons in 2024. The Life Sciences segment is forecasted to grow in the low-double digits, driven by sales increases across all businesses.
Disclaimer: The author does not hold or have a position in any securities discussed in the article.
Back to 
